The state of the science on prostate cancer biomarkers: the San Francisco consensus statement

MR Cooperberg, PR Carroll, MA Dall'Era, BJ Davies… - European urology, 2019 - Elsevier
At every point along the prostate cancer continuum of care, from early detection through to
advanced disease, a man must face decisions that may have a direct impact on his long …

Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiatives

JR Srigley, M Amin, L Boccon-Gibod… - … Journal of Urology …, 2005 - Taylor & Francis
An understanding of prognosis in cancer medicine is important for patient care, research
and cancer control programs. In prostate cancer, prognostic (predictive) factors are …

[PDF][PDF] Guidelines on prostate cancer

N Mottet, J Bellmunt, E Briers… - … Association of Urology, 2015 - file.medtrib.cn
Please note that this text presents an abridged version of the full text Prostate Cancer (PCa)
guidelines and consultation of the more detailed, underlying document, is strongly advised …

Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology

EM Schaeffer, S Srinivas, N Adra, Y An… - Journal of the National …, 2023 - jnccn.org
The NCCN Guidelines for Prostate Cancer provide a framework on which to base decisions
regarding the workup of patients with prostate cancer, risk stratification and management of …

Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study

S Joniau, A Briganti, P Gontero, G Gandaglia, L Tosco… - European urology, 2015 - Elsevier
Background High-risk prostate cancer (PCa) is an extremely heterogeneous disease. A
clear definition of prognostic subgroups is mandatory. Objective To develop a pretreatment …

Predicting prostate cancer death with different pretreatment risk stratification tools: a head-to-head comparison in a nationwide cohort study

R Zelic, H Garmo, D Zugna, P Stattin, L Richiardi… - European urology, 2020 - Elsevier
Background Numerous pretreatment risk classification tools are available for prostate
cancer. Which tool is best in predicting prostate cancer death is unclear. Objective To …

Artificial intelligence predictive model for hormone therapy use in prostate cancer

DE Spratt, S Tang, Y Sun, HC Huang, E Chen… - NEJM …, 2023 - evidence.nejm.org
Background Androgen deprivation therapy (ADT) with radiotherapy can benefit patients with
localized prostate cancer. However, ADT can negatively impact quality of life, and there …

[HTML][HTML] Pre-treatment risk stratification of prostate cancer patients: A critical review

G Rodrigues, P Warde, T Pickles, J Crook… - Canadian Urological …, 2012 - ncbi.nlm.nih.gov
Methods: A systematic literature search was conducted to identify original research
publications and review articles on prognostic factors and risk stratification in prostate …

Prognostic and predictive factors in prostate cancer

FC Hamdy - Cancer treatment reviews, 2001 - Elsevier
Prostate cancer is a major public health problem in the Western world, and the second most
common male malignancies in the European Union. Detection of the disease is possible at …

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model

DR Thurtle, DC Greenberg, LS Lee, HH Huang… - PLoS …, 2019 - journals.plos.org
Background Prognostic stratification is the cornerstone of management in nonmetastatic
prostate cancer (PCa). However, existing prognostic models are inadequate—often using …